Objective: To evaluate the role of newer agents in the management of atrial fibrillation (AF). Data sources: EMBASE and MEDLINE were searched (up to June 2012) combining medication names with ...

In that single-arm study, the rate of primary adverse events within 7 days of ablation was 2.9%, with the most common ...

Pulsed field ablation (PFA) is emerging as an alternative, using non-thermal electric fields to target cardiac tissue while ...

Objective To investigate the association of non-steroidal anti-inflammatory drugs (NSAIDs) and the risk of atrial fibrillation in a prospective community-based follow-up study of elderly individuals ...

Looking back, Kokomo resident Mike Beatty knew he had something as a teenager, but he couldn’t put a name to it.

Dofetilide is under clinical development by Hyloris Pharmaceuticals and currently in Phase I for Atrial Flutter.

The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.

THRV-1268 is under clinical development by Thryv Therapeutics and currently in Phase I for Atrial Fibrillation.

Johnson & Johnson’s JNJ MedTech unit has temporarily paused sales of Varipulse, its pulsed field ablation (PFA) therapy to ...

These days, Beatty takes medications to help control his Afib ... And what exactly is atrial fibrillation anyway? To answer those questions, CNHI News Indiana reached out to Dr.

About 200,000 Louisiana residents are living with a heart condition called atrial fibrillation but there is a new treatment ...

He had a history of atrial fibrillation (AF) that initially occurred 2 years before in the context of streptococcal ...